Pneumonia News and Research

Latest Pneumonia News and Research

Parkinson's disease is an independent risk factor for dying from COVID-19, study suggests

A new study of approximately 80,000 patients shows that people with Parkinson's disease (PD) have a 30% higher risk of dying from COVID-19 than people without the neurodegenerative condition.

1 Oct 2020

AI can be nearly as accurate as a physician in diagnosing COVID-19

The new UCF co-developed algorithm can accurately identify COVID-19 cases, as well as distinguish them from influenza.

30 Sep 2020

Cannabinoids can contribute to negative respiratory health events in older adults with COPD

Cannabinoids, a class of prescription pills that contain synthetically-made chemicals found in marijuana, are associated with a 64 per cent increase in death among older adults with chronic obstructive pulmonary disease (COPD), according to the first published data on the impact of cannabinoids on the respiratory health of individuals with the lung disease.

30 Sep 2020

SARS-CoV-2 re-infection is real but rare: Case study

Now, American researchers have looked at all reported cases of re-infection and the possible reasons behind them. Their study titled, “Re-infection with SARS-CoV-2 and Failure of Humoral Immunity: a case report,” is published online on the preprint server medRxiv in September 2020.

28 Sep 2020

One-third of parents in the U.S. won’t get flu shots for their kids during the pandemic

A survey from the National Poll on Children’s Health, however, revealed that one-third of American parents have no plans of getting their children vaccinated for the flu virus this year during the COVID-19 pandemic.

28 Sep 2020

Study pinpoints heating element in vaping devices as cause for lung injuries

Early results of an experimental vaping study have shown significant lung injury from E-cigarette (eC) devices with nickel-chromium alloy heating elements.

28 Sep 2020

Researchers discover specific cellular pathway involved in lung tissue regeneration

Researchers at Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania have identified a cellular pathway that can be targeted with a naturally occurring drug to stimulate lung tissue regeneration, which is necessary for recovery from multiple lung injuries.

28 Sep 2020

Genetic mutations hinder immune response in severe COVID-19

Now, a truly international team of nearly 140 researchers aimed to determine why some people develop severe illness when once infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease.

28 Sep 2020

Auto-antibodies may explain why some people develop severe COVID-19

Now, a new study by an international team of health experts shows that some life-threatening cases of COVID-19 can be traced to specific weak spots in the patients' immune system.

28 Sep 2020

Special formulation of inhaled niclosamide may be effective against SARS-CoV-2

Now in new research published on the preprint server bioRxix*, a novel formulation of the drug Niclosamide (NIC) is observed to be effective against SARS-CoV-2 and MERS-CoV in mouse models; it also protects against methicillin-resistance Staphylococcus aureus pneumonia and inflammatory lung damage.

28 Sep 2020

Seniors the optimal target for SARS-CoV-2 vaccination

ith several vaccines already in stage 3 clinical trials, a study by University of Warwick researchers and published on the preprint server medRxiv in September 2020 discusses the use of computer modeling techniques in order to achieve optimal vaccine coverage.

28 Sep 2020

Inhaled corticosteroids may not increase COVID-19 mortality

Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.

28 Sep 2020

Study reveals the differences in non-COVID-19 hospital admissions during rebound period

While declines in U.S. hospital admissions during the onset of COVID-19 has been well-documented, little is known about how admissions during the rebound varied by age, insurance coverage and socioeconomic groups.

26 Sep 2020

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

Analysis of samples taken to test for respiratory viruses over the past five years suggests that the emergence of SARS-CoV-2 was associated with a large drop in circulation of other common respiratory viruses during the first wave.

26 Sep 2020

ECMO appears to be saving the lives of many critically ill COVID-19 patients

It saved lives in past epidemics of lung-damaging viruses. Now, the life-support option known as ECMO appears to be doing the same for many of the critically ill COVID-19 patients who receive it, according to a new international study.

26 Sep 2020

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific kind of genetic mutation.

25 Sep 2020

New studies report specific mechanisms of impaired type I interferon signaling in COVID-19 patients

Two new studies report specific mechanisms of impaired type I interferon (IFN) signaling in some hospitalized patients suffering from severe cases of COVID-19, suggesting that screens for these defects could help identify patients at the highest risk of life-threatening complications from SARS-CoV-2 infection.

25 Sep 2020

Individuals with severe forms of COVID-19 disease can have compromised type I interferon responses

Individuals with severe forms of COVID-19 disease can present with compromised type I interferon (IFN) responses based on their genetics, according to results published in two papers today in the journal Science.

25 Sep 2020

New study may explain why more men than women die from COVID-19

New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease.

25 Sep 2020

Human-to-cat transmission of SARS-CoV-2 confirmed

Cat-to-cat transmission of SARS-CoV-2 has been experimentally proven, but little is known about the significance of this novel virus as a feline pathogen or its reverse zoonotic potential. The establishment of new animal reservoirs of SARS-CoV-2 could pose serious problems for human health in the future.

24 Sep 2020

Pneumonia News and Research

Latest Pneumonia News and Research

Parkinson's disease is an independent risk factor for dying from COVID-19, study suggests

AI can be nearly as accurate as a physician in diagnosing COVID-19

Cannabinoids can contribute to negative respiratory health events in older adults with COPD

SARS-CoV-2 re-infection is real but rare: Case study

One-third of parents in the U.S. won’t get flu shots for their kids during the pandemic

Study pinpoints heating element in vaping devices as cause for lung injuries

Researchers discover specific cellular pathway involved in lung tissue regeneration

Genetic mutations hinder immune response in severe COVID-19

Auto-antibodies may explain why some people develop severe COVID-19

Special formulation of inhaled niclosamide may be effective against SARS-CoV-2

Seniors the optimal target for SARS-CoV-2 vaccination

Inhaled corticosteroids may not increase COVID-19 mortality

Study reveals the differences in non-COVID-19 hospital admissions during rebound period

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

ECMO appears to be saving the lives of many critically ill COVID-19 patients

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

New studies report specific mechanisms of impaired type I interferon signaling in COVID-19 patients

Individuals with severe forms of COVID-19 disease can have compromised type I interferon responses

New study may explain why more men than women die from COVID-19

Human-to-cat transmission of SARS-CoV-2 confirmed

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Pneumonia News and Research

Latest Pneumonia News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in